agents do not show any antigenic relationship to rabbit fibroma or the myxoma virus.
Some characteristics of our isolates suggest the presence of a virus of the parainfluenza group. Ether-sensitivity seems to exclude the presence of polyoma virus, and polyoma antisera failed to inhibit hemagglutination. Cell transformation and subsequent tumour formation has been reported in an account of one myxovirus (Leuchtenberger et al. 1965 ) but such behaviour is unknown to us in members of the parainfluenza group.
The possibility of a mixed infection cannot be rejected, but evidence against it exists. The agent was recovered in one band from a sucrose gradient; and if not cloned, it was at least recovered from a cloned culture.
We do not know the factors governing the release of virus from transformed cells in vitro, nor those which led to spontaneous cell lysis with RS21. A difference was observed here between RS6 and RS21; but both these strains and also RS3/2 caused cell transformation and inoculates of the transformed cells produced tumours from which virus was recovered.
There is still the possibility that, in the original host, our isolates were mere passengers. The strains collected from diseased animals appear very similar in all respects to that from an apparently healthy animal. However, the virus titre from diseased animals was appreciably higher, by 6-7 logs.
Dr R J C Harris (Department ofEnvironmental Carcinogenesis, Imperial Cancer Research Fund, London NW7)
Cell-virus Interaction in Virus-induced Animal Tumours
A comparatively short time ago only two tests were available for the investigation of a tumour for virus etiology: (1) Did a cell-free extract transmit the tumour in the same, or another, species ? (2) Could the electronmicroscopists visualize a virus? My own interest in cell-virus interaction dates from the early 1950s when I showed (Harris 1956 ) that turkeys inoculated with a strain of Rous sarcoma virus -RSV(H)normally rejected the tumours induced unless they had been made tolerant to chicken antigens related to blood group A (Forssman-like) substance.
This was a homograft rejection mediated by immune lymphocytes (Harris & Simons 1962 ) and nonviral chicken tumours or chicken skin would graft under similar conditions of tolerance in the turkeys. This was the first tumour virus-induced neo-antigen (neo as far as the adult turkey was concerned!) to be discovered.
Another group of complement-fixing so-called 'T' antigens has now been found in the RSV, and other systems, and I want briefly to discuss the neo-antigens produced in tumour cells induced by DNA and RNA viruses. This is obviously relevant to the questions with which Dr Allison is concerned in the next paper (p 000). Even if virus cannot be recovered from or visualized in the tumour cells, the protein 'finger-prints' left behind in them may incriminate a virus.
DNA Viruses
Let us first consider the DNA viruses -polyoma, SV40 and adenovirus: (1) The 'T' and transplantation antigens are common to tumours induced by the same virus even in different species. (2) These tumours usually lack virion antigens (V) and do not normally release infectious virus.
For both polyoma and SV40 viruses most immunofluorescent studies have located the 'T' antigen in the nuclei of tumour cells or in vitro transformed hamster cells. Mouse, rat or hamster embryo fibroblasts infected by polyoma virus have also been thought to synthesize 'T' antigen before virion antigen (Fogel et al. 1967) .
Hamster tumours induced by adenovirus 12, however, show 'T' antigen in the cytoplasm although it is found as bundles of fibres in the nuclei of infected human amnion cells (Stich et al. 1967 , Kalnins et al. 1967 .
The synthesis of 'T' and 'V' antigens can be separated either by treatment of the culture systems with hydroxyurea or FUDR or by using irradiated virus (Gilden et al. 1968 , Levy et al. 1968 ).
There is some evidence that for the oncogenic adenoviruses the 'T' antigen may be found as an internal component of the virus (Russell & Knight 1967 , Russell et al. 1968 ).
In the polyoma mouse tumour system Negroni & Birnie have been studying the relationship between the neo-antigens. They find 'T' antigen in the cell cytoplasm and, moreover, that the microsomal (membranous) fraction from the tumour cells not only contains the transplantation antigen but also an antigen reacting like a 'T' antigen in the complement-fixation test with specific serum (Negroni & Birnie 1968 ). Attempts to separate these have been unsuccessful for both are associated with particulate cell fractions, and attempts to solubilize them have not been successful.
The 'T' antigen is probably not a single species and Negroni has evidence for at least two such antigens in polyoma (py)-induced mouse tumours. One of these is present in embryo cells from mice of the same strain.
The transplantation antigens induced by the DNA viruses may also be heterogeneous. O'Neill (1968) found that, whereas BHK21 cells were Forssman negative, polyoma or RSV (S-R) transformed cells became Forssman positive, so did BHK cells transformed by the DNA from SV-40 (Robertson & Black 1969 ) but adenovirus transformed hamster or py or SV40 transformed mouse cells did not.
RNA Viruses
Tumours induced by RNA-containing viruses (avian and murine leukemia-sarcoma virus, mouse mammary tumour virus) have the following neo-antigen characteristics: (1) Transplantation antigens are common to cells transformed by the same virus. (2) The tumour cells usually release infective virus except for defective avian viruses. (3) In defective avian viruses, virus release, virus antigenicity and cell specificity may all be determined by a helper virus which appears to supply 'missing' RNA. (4) The complementfixing 'T' antigens of the avian and murine viruses are group-specific (gs). The gs antigen for the avian sarcoma group is detectable in avian and mammalian tumours using sera from hamsters bearing RSV(S-R) induced tumours. It is a curious fact that although the avian virus tumours of mice and rats may contain quite large amounts of gs antigen they are poor produceis of antibody.
Mouse cell lines which synthesize murine leukemia viruses invariably contain the murine gs antigen (Hall et al. 1967 ) and there is some evidence that the murine and feline leukemia viruses, but not avian, may share a gs antigen (Geering et al. 1968 ).
The Cofal antigen, as Huebner first described the avian 'T' antigen, is probably an internal virus component in this group (Eckert et al. 1964) . Again it may not be a single antigen species (Payne & Chubb 1968 , Duesberg et al. 1968 ). It is found in virus-producing cells, and in those mouse tumours induced by RSV(S-R) which are virogenic, i.e. capable of eliciting virus synthesis in association with virus-sensitive chick cells (Bubenik & Bauer 1967) . Tumours induced in rats by RSV(S-R), however, are different. Zilber et al. (1967) found no gs antigen or antibody in these and neither did we (Harris et al. 1969 ), even in virogenic clones.
The rat tumours in our study were not immunogenic and we concluded that the association of Rous virus 'genome' with tumour cell genome could produce at least three different results: There are (1) tumour cells which can synthesize infectious virus; virion, group-specific and transplantation antigens can be demonstrated; (2) tumour cells which cannot make virus but are virogenic in association with susceptible chick cells and may, or may not, have detectable antigens; (3) tumour cells which are neither virusproducing nor virogenic and do not have detectable neo-antigens.
SV-40 virus variants can be produced by irradiation and Coppey & Wicher (1968) have shown that only about one-third of the genome is required for 'T' antigen synthesis. We can anticipate that more detailed studies of the interaction of virus and cell genomes will be made, the biochemical properties of these neo-antigens elucidated and their relationship to normal cell antigens determined. I am not convinced that their identification in tumour cells provides positive evidence for integration of a specific viral genomethis will depend upon their relationship to normal antigens both embryonic and adult; neither am I convinced that their absence provides negative evidence.
It is also apparent that the neo-antigens induced in tumour cells by the DNA viruses are more easy to demonstrate than those induced by RNA viruses. DNA synthesis has been shown to be necessary for the production of RSV and of mouse sarcoma virus (MSV). It may be that the extra step required for transformation by the RNA viruses, i.e. production of a complementary DNA for integration into the cell's genome, leads to a greater possibility of partial integration and subsequent loss of some of the potential functions of the whole virus genome.
